Welcome to our dedicated page for Innospec SEC filings (Ticker: IOSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating sulfur-additive margins or tracking drilling-fluid risks in Innospec’s disclosures can feel like chemistry lab work. Each 10-K, 10-Q, or 8-K packs dense environmental data, raw-material cost tables, and global plant statistics that busy analysts struggle to decode.
Stock Titan’s AI solves that problem. Our platform turns every Innospec SEC filing into plain-English insights. Want the Innospec annual report 10-K simplified? We highlight segment revenue and emission liabilities in seconds. Need the latest Innospec quarterly earnings report 10-Q filing? AI pulls out surfactant volume trends while you sip coffee. Curious about Innospec 8-K material events explained? Real-time alerts flag refinery outages or leadership changes before markets react.
The page updates the moment EDGAR releases anything—whether it’s Innospec insider trading Form 4 transactions or a definitive proxy detailing executive incentives. You’ll find:
- Form 4 dashboards for Innospec executive stock transactions Form 4 with instant email and SMS alerts—perfect for tracking buying or selling by key chemists and officers.
- AI-written summaries that make understanding Innospec SEC documents with AI as simple as reading a headline.
- Side-by-side redlines that power deeper Innospec earnings report filing analysis across quarters.
Whether you’re assessing compliance costs, monitoring Innospec proxy statement executive compensation, or just need Innospec SEC filings explained simply, Stock Titan delivers every disclosure—decoded and delivered in real time.
Innospec Inc. (IOSP) reported third-quarter 2025 results. Net sales were $441.9 million versus $443.4 million a year ago. Operating income fell to $5.9 million from $45.6 million, and net income was $12.9 million, or $0.52 diluted EPS, compared with $33.4 million, or $1.33 diluted EPS.
Segment trends were mixed. Performance Chemicals sales rose 4% to $170.8 million but gross margin declined to 15.1% on pricing erosion and mix. Fuel Specialties grew 4% to $172.0 million with gross margin up to 35.6% on improved mix and disciplined pricing. Oilfield Services declined 13% to $99.1 million, while gross margin improved to 30.0% on mix.
Results included a $22.9 million impairment of property, plant and equipment and a $19.1 million impairment of intangible assets, partly offset by a $17.7 million credit from contingent consideration revaluation. Cash and cash equivalents were $270.8 million with no borrowings on the $250.0 million revolver. Year-to-date operating cash flow was $76.9 million; the company paid dividends of $20.8 million and repurchased $23.9 million of common stock. Shares outstanding were 24,777,582 as of October 31, 2025.
Innospec Inc. reported that it issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The company also declared a semi-annual dividend of $0.87 per share on its common stock.
The dividend will be paid on November 26, 2025 to shareholders of record as of November 18, 2025. The press release was furnished as Exhibit 99.1, providing details on the quarter’s performance.
Innospec’s Q2 2025 10-Q shows mixed performance. Net sales rose 1% YoY to $439.7 m, but net income fell 25% to $23.5 m (EPS $0.94). Lower profitability stemmed from a 120 bp drop in aggregate gross margin to 28.0% and a 3% rise in operating expenses; operating income declined 16% to $34.3 m.
Segment results were uneven: Fuel Specialties boosted gross margin 350 bp to 38.1% and operating income 16% to $35.4 m, while Performance Chemicals margin contracted 510 bp and Oilfield Services revenue fell 7%. For the first half, sales slipped 6% to $880.5 m and net income dropped 22% to $56.3 m (diluted EPS $2.24).
Cash from operations shrank to $37.6 m (-56% YoY) as inventories climbed $35.8 m. Nevertheless, cash & equivalents remain solid at $266.6 m; the $250 m revolver is undrawn and the company carries no long-term debt. Equity improved to $1.30 bn on retained earnings and a $57.6 m favorable FX translation adjustment.
Capital deployment included $32.2 m of capex/ERP spend, $20.8 m dividends ($0.84 / share) and $13.3 m share buybacks under a new $50 m program. Plant-closure provisions were raised $4.1 m and FX hedges produced a $6.4 m loss. Management cites softer demand in Oilfield Services and price pressure in Performance Chemicals, but highlights margin gains in Fuel Specialties and low leverage.
FAQ
What is the current stock price of Innospec (IOSP)?
What is the market cap of Innospec (IOSP)?
